Sanders and co-workers demonstrated increased expression of ALDH1A2 in GBM compared to the expression detected in low-grade gliomas and upregulation of ALDH1A2 expression upon GBM recurrence [395]. This evidence concerns the gene ALDH1A2 and glioma.